Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    9777836 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Effect of Butyrogenic Fibers in IBS Patients
Condition: Irritable Bowel Syndrome
Intervention: Drug: Diet
2 Terminated The Use of VSL#3 in Irritable Bowel Syndrome in Children
Condition: Irritable Bowel Syndrome
Interventions: Other: Placebo;   Drug: VSL#3 900 billion bacteria;   Drug: VSL#3 90 billion bacteria

Indicates status has not been verified in more than two years